Form 4 for ABT Abbott Laboratories
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001104659-23-077919 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-05 | 2023-06-30 | ABT | Morrone Louis H. | EVP | A - Grant | $0.00 | +1,815 | 55.5K | +3% | $0 |
| D | 2023-07-05 | 2023-07-01 | ABT | Morrone Louis H. | EVP | F - Tax | $109.02 | -556 | 54.9K | -1% | -$60.6K |
| D | 2023-07-05 | 2023-06-30 | ABT | Morrone Louis H. | EVP | A - Grant | $0.00 | +7,100 | 7,100 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-06-30 | A | A | 1,815 | $0.00 | 55,471 | D | — | — | (F1) These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. |
| 2 | Common | Common shares without par value | 2023-07-01 | F | D | 556 | $109.02 | 54,915 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2023-06-30 | A | A | 7,100 | $0.00 | 7,100 | D | $108.52 · 2024-06-30 to 2033-06-29 | 7,100 Common Shares | (F3) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 2,366 on June 30, 2024, 2,367 on June 30, 2025, and 2,367 on June 30, 2026. |